Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Edesa Biotech Inc (EDSA)

Edesa Biotech Inc (EDSA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 58,192
  • Shares Outstanding, K 10,523
  • Annual Sales, $ 330 K
  • Annual Income, $ -6,360 K
  • 60-Month Beta 0.57
  • Price/Sales 185.19
  • Price/Cash Flow N/A
  • Price/Book 7.28
Trade EDSA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.19
  • Number of Estimates 2
  • High Estimate -0.16
  • Low Estimate -0.22
  • Prior Year -0.15
  • Growth Rate Est. (year over year) -26.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.05 +81.76%
on 01/04/21
9.10 -19.01%
on 01/26/21
+2.58 (+53.86%)
since 12/24/20
3-Month
4.05 +81.76%
on 01/04/21
9.10 -19.01%
on 01/26/21
+1.04 (+16.43%)
since 10/26/20
52-Week
1.58 +366.46%
on 03/18/20
19.10 -61.41%
on 07/30/20
+4.27 (+137.74%)
since 01/24/20

Most Recent Stories

More News
Thinking about buying stock in Edesa Biotech, Phunware, Vertex Energy, electroCore, or Selecta Biosciences?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EDSA, PHUN, VTNR, ECOR, and SELB.

ECOR : 3.06 (+11.68%)
EDSA : 7.42 (+34.18%)
PHUN : 1.8100 (+24.83%)
SELB : 4.31 (+6.42%)
VTNR : 2.2700 (+39.26%)
Edesa Biotech to Study Its Investigational Drug as Potential Rescue Therapy

TORONTO, ON / ACCESSWIRE / January 26, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, has received regulatory approval from the U.S. Food and Drug Administration...

EDSA : 7.42 (+34.18%)
Edesa Biotech to Join Panel Discussion at Government COVID-19 Event

TORONTO, ON / ACCESSWIRE / January 20, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, announced today that Dr. Par Nijhawan, Chief Executive Officer, is scheduled...

EDSA : 7.42 (+34.18%)
Edesa Biotech Expands COVID-19 Clinical Study to Colombia

TORONTO, ON / ACCESSWIRE / January 11, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, has received approval from the Ministry of Health (INVIMA) in Colombia to expand...

EDSA : 7.42 (+34.18%)
Edesa Biotech Issues Letter to Shareholders

TORONTO, ON / ACCESSWIRE / December 30, 2020 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, issued a letter to shareholders from its Chief Executive Officer, Par Nijhawan,...

EDSA : 7.42 (+34.18%)
Edesa Biotech Reports Fiscal Year 2020 Results

Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, today reported financial results for the fiscal year ended September 30, 2020 and provided an update on its business.

EDSA : 7.42 (+34.18%)
Edesa Biotech Enrolls First Patient in COVID-19 Study

TORONTO, ON / ACCESSWIRE / November 30, 2020 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, today announced that the first patient has been enrolled in a Phase 2/Phase3...

EDSA : 7.42 (+34.18%)
Edesa Biotech to Present at H.C. Wainwright & Co. 6th Annual Israel Conference

TORONTO, ON / ACCESSWIRE / November 6, 2020 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, announced today that Dr. Par Nijhawan, Chief Executive Officer, is scheduled...

EDSA : 7.42 (+34.18%)
Edesa Biotech Achieves Enrollment Milestone in Dermatitis Study

TORONTO, ON / ACCESSWIRE / November 3, 2020 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, today announced that it has completed enrollment of more than 50% of the patients...

EDSA : 7.42 (+34.18%)
Edesa Biotech Receives Approval to Initiate COVID-19 Study in the U.S.

TORONTO, ON / ACCESSWIRE / October 19, 2020 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, has received clearance from the U.S. Food and Drug Administration (FDA) to begin...

EDSA : 7.42 (+34.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Edesa Biotech Inc. is a biopharmaceutical company. It is focused on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs. The company's product pipeline consists of EB01, EB02 and EB04 which are in clinical stage....

See More

Key Turning Points

3rd Resistance Point 6.59
2nd Resistance Point 6.24
1st Resistance Point 5.89
Last Price 7.42
1st Support Level 5.19
2nd Support Level 4.84
3rd Support Level 4.49

See More

52-Week High 19.10
Fibonacci 61.8% 12.41
Fibonacci 50% 10.34
Fibonacci 38.2% 8.27
Last Price 7.42
52-Week Low 1.58

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar